Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RI00212
Host Cell : HEK293 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RI00212 |
| Description | This cell line is engineered to stably express Homo sapiens (human) sodium voltage-gated channel alpha subunit 5 (SCN5A) in Human immortalized embryonic kidney cell line (HEK293). GFP reporter gene is also expressed in this cell line allowing fluorescent tracking of cells. |
| Product Type | Human gene overexpression stable cell line |
| Target Gene | SCN5A |
| Gene Species | Homo sapiens (human) |
| Host Cell | HEK293 |
| Host Cell Species | Homo sapiens (Human) |
| Reporter | GFP |
| Applications |
1) investigation of gene function 2) screening and validation of antibodies |
| Size | One vial of frozen cells, typically >1x10^6cells/vial |
| Stability | This cell line is stable at least 10 passages. |
| Quality Control |
1) Real-time qPCR analysis of gene mRNA overexpression level 2) GFP fluorescent detection under fluorescent microscopy 3) mycoplasma detection |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Growth Properties | Adherent |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | SCN5A |
| Gene Symbol | SCN5A |
| GeneID | 6331 |
The SCN5A gene encodes the principal alpha subunit of the cardiac voltage-gated sodium channel (Nav1.5). This integral membrane protein is predominantly expressed in cardiac muscle tissue and plays a critical role in the electrophysiological function of the human heart. The Nav1.5 channel is directly responsible for generating the rapid inward flux of sodium ions during the initial depolarization phase (Phase 0) of the cardiac action potential. This massive yet extremely transient inward sodium current constitutes the fundamental physiological event that initiates and propagates electrical impulses throughout the atria and ventric, thereby ensuring the synchronized contraction of the myocardium and the maintenance of a normal, stable heart rhythm. Genetic mutations in this gene are widely recognized as the underlying cause of various severe inherited cardiac channelopathies. Loss-of-function mutations are typically associated with Brugada syndrome, progressive cardiac conduction block, and sick sinus syndrome—conditions that predispose individuals to severe ventricular arrhythmias and place them at risk of sudden cardiac death. Conversely, gain-of-function mutations that result in delayed inactivation of the sodium channel are the primary cause of Long QT Syndrome Type 3 (LQTS3); this disorder is similarly characterized by a high risk of lethal arrhythmic events.
The Human SCN5A Stable Cell Line (HEK293) was generated by precisely integrating the full-length human SCN5A gene sequence into the human embryonic kidney 293 (HEK293) cell line. This process ensures robust, consistent, and highly functional expression of the Nav1.5 channel at the cell surface—a characteristic that is faithfully maintained throughout successive cell passages. This stable cell line has emerged as the "gold standard" platform in the field of both manual and automated patch-clamp electrophysiology, enabling researchers to precisely record Nav1.5 peak currents, meticulously dissect channel gating kinetics, and observe complex, state-dependent biophysical properties in real time. Beyond fundamental electrophysiological research, this cell line is extensively utilized in large-scale, high-throughput screening campaigns aimed at identifying novel therapeutic modulators and specific sodium channel blockers for the treatment of severe cardiac arrhythmias.
In cardiomyocytes, the voltage-gated transient outward potassium current (Ito) is responsible for Phase 1 repolarization of the cardiac action potential (AP). Gain-of-function mutations in KCND3-the gene encoding the Kv4.3 channel that carries Ito-have been established as being associated with Brugada syndrome (BrS). Recent studies suggest that an augmentation of Ito may directly impact cardiac conduction function. Here, researchers investigated the effects of Kv4.3 overexpression on Nav1.5 currents and the consequent availability of sodium channels. The cardiac sodium current (INa), generated by the voltage-gated sodium channel Nav1.5 (encoded by the SCN5A gene), is responsible for driving the rapid upstroke phase of the cardiac action potential (AP). The researchers found that in HEK293 cells stably expressing Nav1.5 (i.e., HEK293-Nav1.5 cells), overexpression of the Kv4.3 protein significantly reduced Nav1.5 current density, yet did not alter its kinetic properties. Furthermore, measurements utilizing alternating voltage/current-clamp techniques revealed that Kv4.3 overexpression reduced the maximum upstroke velocity of action potentials in HEK293-Nav1.5 cells. These effects induced by Kv4.3 could not be explained solely by changes in the total expression levels of the Nav1.5 protein. Through further simulations utilizing multicellular computational models, the researchers confirmed that the experimentally observed phenomenon-namely, the simultaneous augmentation of Kv4.3 currents and attenuation of Nav1.5 currents-could potentially lead to cardiac conduction block, thereby underscoring the potential functional significance of the findings presented in this study.
Here, researchers characterized the effects of Kv4.3 overexpression on Nav1.5-based currents in HEK293-Nav1.5 cells. Figure 1A displays representative Nav1.5 currents activated by depolarizing voltage-clamp steps-starting from a holding potential of −120 mV, with 5 mV increments and a duration of 500 ms-in HEK293-Nav1.5 cells transfected with either IRES-GFP or KCND3-IRES-GFP. Under both conditions, Nav1.5 currents began to activate around −60 mV, reached a peak around −30 mV, and subsequently declined in amplitude due to the diminishing driving force for Na+. Compared to cells transfected with IRES-GFP, cells transfected with KCND3-IRES-GFP exhibited significantly lower Nav1.5 current densities (Figure 1B). Next, the researchers determined whether the reduction in Nav1.5 current density was accompanied by alterations in gating properties. No significant differences were observed in the t50% (half-decay time) between cells transfected with IRES-GFP and those transfected with KCND3-IRES-GFP. To determine the voltage dependence of the activation process in cells transfected with IRES-GFP versus KCND3-IRES-GFP, the I-V relationship curves shown in Figure 1B were first corrected for the Na+ driving force. Notably, the Nav1.5 current reversal potential calculated using the Nernst equation was approximately +17.58 mV, a value consistent with the sodium current recordings shown in Figure 1A. Subsequently, the current amplitudes were normalized (relative to their maximum amplitudes), and the resulting curves were fitted with a Boltzmann distribution function. Figure 1C illustrates the superposition of the voltage-dependence curves for the inactivation process. These inactivation curves were constructed by normalizing the current amplitudes to the maximum current value elicited during the −20 mV voltage-clamp step. Similarly, Figure 1D illustrates the overlap of the voltage-dependence curves for the activation process in cells transfected with IRES-GFP and KCND3-IRES-GFP. These data indicate that neither the voltage dependence of activation nor that of inactivation of the Nav1.5 current was affected by the expression of Kv4.3.
Figure 1. Kv4.3 overexpression reduces Nav1.5 currents. (Portero, Vincent, et al., 2018)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
This SCN5A line is perfect for our sodium channel electrophysiology assays. The current density is optimal for patch-clamp recording without being 'over-expressed' to the point of toxicity.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.